Skip to main content
. Author manuscript; available in PMC: 2017 Apr 5.
Published in final edited form as: J Hepatol. 2015 Nov 30;64(4):899–907. doi: 10.1016/j.jhep.2015.11.028

Table 1. Parameters of serum chemistry in mice treated with different combinations of siRNA targeting Hippo pathway.

PBS si-Control Triple siRNA si-Mst2+si-NF2 si-Mst1+si-NF2
Albumin, g/dl 2.90±0.12 2.89±0.22 3.31±0.15* 3.14±0.17# 2.96±0.11
Total protein, g/dl 4.7±0.1 4.9±0.2 5.5±0.2** 5.2±0.2## 5.0±0.2
Globulin, g/dl 1.82±0.08 2.06±0.05 2.24±0.11* 2.1±0.07# 2.06±0.11
Blood urine nitroqen, mg/dl 19.2±2.3 20.5±2.5 18.5±1.9 21.4±2.8 19.4±1.1
Alkaline phosphatase (ALP), IU/I 101.5±14.4 116.3±17.9 209.2±87.4* 125.8±31.5# 108.7±10.9#
ALT (SGPT), IU/I 19±2.4 24.1 ±8.9 50.9±15.7 52.9±28.7# 19.8±1.6
AST (SGOT), IU/I 47.8±16.8 67.4±29.1 65.9±3.2 83.5±12.1 59.7±11.4
Direct bilirubin, mg/dl 0.04±0.024 0.023±0.015 0.228±0.189* 0.042±0.017# 0.023±0.011#
Total bilirubin, mg/dl 0.178±0.046 0.140±0.036 0.448±0.244* 0.186±0.032## 0.132±0.013#
Total bile acids, mg/dl 6.1±1 8.9±2.6 91.4±33*** 25.5±5.6### 15.1±1.8###
Cholesterol, mg/dl 68.5±10.4 76.3±10.2 125.6±20.4*** 87.2±6.6### 88.7±5###
Triglycerides, mg/dl 90.9±24.3 80.5±18.2 90.2±10.4 45.4±4.7*,# 70.3±7.5
HDL, mg/dl 39.4±6.9 39.5±6.7 39.1 ±2.4 32.3±2 42.6±1.8
LDL, mg/dl 6.1±0.6 9.9±0.8 27.6±4.5*** 23.3±1.9*** 14.8±2.6###
Glucose, mg/dl 231.9±46.8 233.4±22.4 152.5±15.7* 208.3±34.8 214.3±48.1
*,**, ***

- p<0.05, p<0.01, p<0.001 comparison vs si-Control

#, ##, ###

- p<0.05, p<0.01, p<0.001 comparison vs Triple siRNA